Merck subsidiary MSD Netherlands closes €3.4B offering of senior notes across four tranches

Merck & Co., Inc.

€850M each of 3.250% notes due 2032, 3.500% notes due 2037, 3.700% notes due 2044, 3.750% notes due 2054.
Notes are fully and unconditionally guaranteed on an unsecured senior basis by Merck & Co., Inc.
All 12 director nominees elected with 84.78%-99.49% of votes cast; advisory say-on-pay approved at 93.50%.
Shareholder proposals on written consent, censorship, and workforce civil liberties all defeated.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.